This not only is supported by bio-informatic data in GEPIA database from TCGA patient cohort, but also analysis of our own clinical samples, indicating that GRM4 is not a decisive factor in the OS of breast cancer patients. This evidence concerns the gene GRM4 and breast carcinoma.